Global NHS-Activated MagBeads Supply, Demand and Key Producers, 2026-2032

June 2026 | 97 pages | ID: G51273BFC3F4EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global NHS-Activated MagBeads market size is expected to reach $ 362 million by 2032, rising at a market growth of 5.7% CAGR during the forecast period (2026-2032).

NHS-Activated MagBeads are superparasitic nano-magnetic bead microspheres containing NHS (succinimide) functional groups, which can be coupled with primary amines on nucleic acids, proteins, antibodies or other molecules to form stable amide bonds. The coupled magnetic beads can be separated from the solution by magnetic field adsorption, and can be directly used in downstream enzyme reactions or immunopurification and separation of macromolecules. In 2025, global NHS-Activated MagBeads production reached approximately 11,354 K ML, with an average global market price of around US$ 21 per ML.

NHS activated magnetic beads belong to the functional sub products with high technical barriers in the magnetic bead industry. Compared with ordinary carboxyl or amino magnetic beads, their core advantage lies in 'pre activation+one-step coupling', which significantly reduces experimental complexity and improves coupling efficiency. Therefore, they are irreplaceable in the fields of antibody coupling, protein immobilization, and immunoassay. Currently, the global market is dominated by high-end products from European and American companies, and Chinese manufacturers are rapidly improving in cost-effectiveness and large-scale production. The industry as a whole is showing a medium to high growth trend, with demand mainly driven by biopharmaceutical research and development, monoclonal antibody drug development, in vitro diagnosis, and automated experimental platforms. In the future, products will move towards high stability NHS The ester system, long arm connection structure, and low non-specific adsorption direction have been upgraded, while the permeability in high-throughput and automation applications continues to increase. However, they also face technical challenges such as activation stability, storage conditions, and batch consistency.

This report studies the global NHS-Activated MagBeads production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for NHS-Activated MagBeads and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of NHS-Activated MagBeads that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global NHS-Activated MagBeads total production and demand, 2021-2032, (US$/mL)
Global NHS-Activated MagBeads total production value, 2021-2032, (USD Million)
Global NHS-Activated MagBeads production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (US$/mL), (based on production site)
Global NHS-Activated MagBeads consumption by region & country, CAGR, 2021-2032 & (US$/mL)
U.S. VS China: NHS-Activated MagBeads domestic production, consumption, key domestic manufacturers and share
Global NHS-Activated MagBeads production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (US$/mL)
Global NHS-Activated MagBeads production by Type, production, value, CAGR, 2021-2032, (USD Million) & (US$/mL)
Global NHS-Activated MagBeads production by Application, production, value, CAGR, 2021-2032, (USD Million) & (US$/mL)

This report profiles key players in the global NHS-Activated MagBeads market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent, Miltenyi Biotec, Bioclone, Cube Biotech, Cytiva, CD Bioparticles, BEAVER, Beijing Biomed Gene Technology, Yeasen Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World NHS-Activated MagBeads market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (US$/mL) and average price (US$/Milliliter) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global NHS-Activated MagBeads Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global NHS-Activated MagBeads Market, Segmentation by Type:
  • Agarose Based
  • Silicon Based
  • Starch Based
Global NHS-Activated MagBeads Market, Segmentation by Particle Size:
  • Particle Size<50?m
  • Particle Size50-100?m
  • Particle Size>100?m
Global NHS-Activated MagBeads Market, Segmentation by Suspension Concentration:
  • Suspension Concentration 10% (V/V)
  • Suspension Concentration 20% (V/V)
  • Suspension Concentration 25% (V/V)
Global NHS-Activated MagBeads Market, Segmentation by Application:
  • Protein Purification
  • Immunoassay
  • Cell Screening
  • Others
Companies Profiled:
  • Thermo Fisher Scientific
  • Agilent
  • Miltenyi Biotec
  • Bioclone
  • Cube Biotech
  • Cytiva
  • CD Bioparticles
  • BEAVER
  • Beijing Biomed Gene Technology
  • Yeasen Biotechnology
Key Questions Answered:
1. How big is the global NHS-Activated MagBeads market?
2. What is the demand of the global NHS-Activated MagBeads market?
3. What is the year over year growth of the global NHS-Activated MagBeads market?
4. What is the production and production value of the global NHS-Activated MagBeads market?
5. Who are the key producers in the global NHS-Activated MagBeads market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 NHS-Activated MagBeads Introduction
1.2 World NHS-Activated MagBeads Supply & Forecast
  1.2.1 World NHS-Activated MagBeads Production Value (2021 & 2025 & 2032)
  1.2.2 World NHS-Activated MagBeads Production (2021-2032)
  1.2.3 World NHS-Activated MagBeads Pricing Trends (2021-2032)
1.3 World NHS-Activated MagBeads Production by Region (Based on Production Site)
  1.3.1 World NHS-Activated MagBeads Production Value by Region (2021-2032)
  1.3.2 World NHS-Activated MagBeads Production by Region (2021-2032)
  1.3.3 World NHS-Activated MagBeads Average Price by Region (2021-2032)
  1.3.4 North America NHS-Activated MagBeads Production (2021-2032)
  1.3.5 Europe NHS-Activated MagBeads Production (2021-2032)
  1.3.6 China NHS-Activated MagBeads Production (2021-2032)
  1.3.7 Japan NHS-Activated MagBeads Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 NHS-Activated MagBeads Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 NHS-Activated MagBeads Major Market Trends

2 DEMAND SUMMARY

2.1 World NHS-Activated MagBeads Demand (2021-2032)
2.2 World NHS-Activated MagBeads Consumption by Region
  2.2.1 World NHS-Activated MagBeads Consumption by Region (2021-2026)
  2.2.2 World NHS-Activated MagBeads Consumption Forecast by Region (2027-2032)
2.3 United States NHS-Activated MagBeads Consumption (2021-2032)
2.4 China NHS-Activated MagBeads Consumption (2021-2032)
2.5 Europe NHS-Activated MagBeads Consumption (2021-2032)
2.6 Japan NHS-Activated MagBeads Consumption (2021-2032)
2.7 South Korea NHS-Activated MagBeads Consumption (2021-2032)
2.8 ASEAN NHS-Activated MagBeads Consumption (2021-2032)
2.9 India NHS-Activated MagBeads Consumption (2021-2032)

3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World NHS-Activated MagBeads Production Value by Manufacturer (2021-2026)
3.2 World NHS-Activated MagBeads Production by Manufacturer (2021-2026)
3.3 World NHS-Activated MagBeads Average Price by Manufacturer (2021-2026)
3.4 NHS-Activated MagBeads Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global NHS-Activated MagBeads Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for NHS-Activated MagBeads in 2025
  3.5.3 Global Concentration Ratios (CR8) for NHS-Activated MagBeads in 2025
3.6 NHS-Activated MagBeads Market: Overall Company Footprint Analysis
  3.6.1 NHS-Activated MagBeads Market: Region Footprint
  3.6.2 NHS-Activated MagBeads Market: Company Product Type Footprint
  3.6.3 NHS-Activated MagBeads Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: NHS-Activated MagBeads Production Value Comparison
  4.1.1 United States VS China: NHS-Activated MagBeads Production Value Comparison (2021 & 2025 & 2032)
  4.1.2 United States VS China: NHS-Activated MagBeads Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: NHS-Activated MagBeads Production Comparison
  4.2.1 United States VS China: NHS-Activated MagBeads Production Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: NHS-Activated MagBeads Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: NHS-Activated MagBeads Consumption Comparison
  4.3.1 United States VS China: NHS-Activated MagBeads Consumption Comparison (2021 & 2025 & 2032)
  4.3.2 United States VS China: NHS-Activated MagBeads Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based NHS-Activated MagBeads Manufacturers and Market Share, 2021-2026
  4.4.1 United States Based NHS-Activated MagBeads Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers NHS-Activated MagBeads Production Value (2021-2026)
  4.4.3 United States Based Manufacturers NHS-Activated MagBeads Production (2021-2026)
4.5 China Based NHS-Activated MagBeads Manufacturers and Market Share
  4.5.1 China Based NHS-Activated MagBeads Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers NHS-Activated MagBeads Production Value (2021-2026)
  4.5.3 China Based Manufacturers NHS-Activated MagBeads Production (2021-2026)
4.6 Rest of World Based NHS-Activated MagBeads Manufacturers and Market Share, 2021-2026
  4.6.1 Rest of World Based NHS-Activated MagBeads Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers NHS-Activated MagBeads Production Value (2021-2026)
  4.6.3 Rest of World Based Manufacturers NHS-Activated MagBeads Production (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World NHS-Activated MagBeads Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Agarose Based
  5.2.2 Silicon Based
  5.2.3 Starch Based
5.3 Market Segment by Type
  5.3.1 World NHS-Activated MagBeads Production by Type (2021-2032)
  5.3.2 World NHS-Activated MagBeads Production Value by Type (2021-2032)
  5.3.3 World NHS-Activated MagBeads Average Price by Type (2021-2032)

6 MARKET ANALYSIS BY PARTICLE SIZE

6.1 World NHS-Activated MagBeads Market Size Overview by Particle Size: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Particle Size
  6.2.1 Particle Size<50?m
  6.2.2 Particle Size50-100?m
  6.2.3 Particle Size>100?m
6.3 Market Segment by Particle Size
  6.3.1 World NHS-Activated MagBeads Production by Particle Size (2021-2032)
  6.3.2 World NHS-Activated MagBeads Production Value by Particle Size (2021-2032)
  6.3.3 World NHS-Activated MagBeads Average Price by Particle Size (2021-2032)

7 MARKET ANALYSIS BY SUSPENSION CONCENTRATION

7.1 World NHS-Activated MagBeads Market Size Overview by Suspension Concentration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Suspension Concentration
  7.2.1 Suspension Concentration 10% (V/V)
  7.2.2 Suspension Concentration 20% (V/V)
  7.2.3 Suspension Concentration 25% (V/V)
7.3 Market Segment by Suspension Concentration
  7.3.1 World NHS-Activated MagBeads Production by Suspension Concentration (2021-2032)
  7.3.2 World NHS-Activated MagBeads Production Value by Suspension Concentration (2021-2032)
  7.3.3 World NHS-Activated MagBeads Average Price by Suspension Concentration (2021-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World NHS-Activated MagBeads Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
  8.2.1 Protein Purification
  8.2.2 Immunoassay
  8.2.3 Cell Screening
  8.2.4 Others
8.3 Market Segment by Application
  8.3.1 World NHS-Activated MagBeads Production by Application (2021-2032)
  8.3.2 World NHS-Activated MagBeads Production Value by Application (2021-2032)
  8.3.3 World NHS-Activated MagBeads Average Price by Application (2021-2032)

9 COMPANY PROFILES

9.1 Thermo Fisher Scientific
  9.1.1 Thermo Fisher Scientific Details
  9.1.2 Thermo Fisher Scientific Major Business
  9.1.3 Thermo Fisher Scientific NHS-Activated MagBeads Product and Services
  9.1.4 Thermo Fisher Scientific NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.1.5 Thermo Fisher Scientific Recent Developments/Updates
  9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Agilent
  9.2.1 Agilent Details
  9.2.2 Agilent Major Business
  9.2.3 Agilent NHS-Activated MagBeads Product and Services
  9.2.4 Agilent NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.2.5 Agilent Recent Developments/Updates
  9.2.6 Agilent Competitive Strengths & Weaknesses
9.3 Miltenyi Biotec
  9.3.1 Miltenyi Biotec Details
  9.3.2 Miltenyi Biotec Major Business
  9.3.3 Miltenyi Biotec NHS-Activated MagBeads Product and Services
  9.3.4 Miltenyi Biotec NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.3.5 Miltenyi Biotec Recent Developments/Updates
  9.3.6 Miltenyi Biotec Competitive Strengths & Weaknesses
9.4 Bioclone
  9.4.1 Bioclone Details
  9.4.2 Bioclone Major Business
  9.4.3 Bioclone NHS-Activated MagBeads Product and Services
  9.4.4 Bioclone NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.4.5 Bioclone Recent Developments/Updates
  9.4.6 Bioclone Competitive Strengths & Weaknesses
9.5 Cube Biotech
  9.5.1 Cube Biotech Details
  9.5.2 Cube Biotech Major Business
  9.5.3 Cube Biotech NHS-Activated MagBeads Product and Services
  9.5.4 Cube Biotech NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.5.5 Cube Biotech Recent Developments/Updates
  9.5.6 Cube Biotech Competitive Strengths & Weaknesses
9.6 Cytiva
  9.6.1 Cytiva Details
  9.6.2 Cytiva Major Business
  9.6.3 Cytiva NHS-Activated MagBeads Product and Services
  9.6.4 Cytiva NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.6.5 Cytiva Recent Developments/Updates
  9.6.6 Cytiva Competitive Strengths & Weaknesses
9.7 CD Bioparticles
  9.7.1 CD Bioparticles Details
  9.7.2 CD Bioparticles Major Business
  9.7.3 CD Bioparticles NHS-Activated MagBeads Product and Services
  9.7.4 CD Bioparticles NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.7.5 CD Bioparticles Recent Developments/Updates
  9.7.6 CD Bioparticles Competitive Strengths & Weaknesses
9.8 BEAVER
  9.8.1 BEAVER Details
  9.8.2 BEAVER Major Business
  9.8.3 BEAVER NHS-Activated MagBeads Product and Services
  9.8.4 BEAVER NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.8.5 BEAVER Recent Developments/Updates
  9.8.6 BEAVER Competitive Strengths & Weaknesses
9.9 Beijing Biomed Gene Technology
  9.9.1 Beijing Biomed Gene Technology Details
  9.9.2 Beijing Biomed Gene Technology Major Business
  9.9.3 Beijing Biomed Gene Technology NHS-Activated MagBeads Product and Services
  9.9.4 Beijing Biomed Gene Technology NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.9.5 Beijing Biomed Gene Technology Recent Developments/Updates
  9.9.6 Beijing Biomed Gene Technology Competitive Strengths & Weaknesses
9.10 Yeasen Biotechnology
  9.10.1 Yeasen Biotechnology Details
  9.10.2 Yeasen Biotechnology Major Business
  9.10.3 Yeasen Biotechnology NHS-Activated MagBeads Product and Services
  9.10.4 Yeasen Biotechnology NHS-Activated MagBeads Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.10.5 Yeasen Biotechnology Recent Developments/Updates
  9.10.6 Yeasen Biotechnology Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 NHS-Activated MagBeads Industry Chain
10.2 NHS-Activated MagBeads Upstream Analysis
  10.2.1 NHS-Activated MagBeads Core Raw Materials
  10.2.2 Main Manufacturers of NHS-Activated MagBeads Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 NHS-Activated MagBeads Production Mode
10.6 NHS-Activated MagBeads Procurement Model
10.7 NHS-Activated MagBeads Industry Sales Model and Sales Channels
  10.7.1 NHS-Activated MagBeads Sales Model
  10.7.2 NHS-Activated MagBeads Typical Distributors

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES

Table 1. World NHS-Activated MagBeads Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World NHS-Activated MagBeads Production Value by Region (2021-2026) & (USD Million)
Table 3. World NHS-Activated MagBeads Production Value by Region (2027-2032) & (USD Million)
Table 4. World NHS-Activated MagBeads Production Value Market Share by Region (2021-2026)
Table 5. World NHS-Activated MagBeads Production Value Market Share by Region (2027-2032)
Table 6. World NHS-Activated MagBeads Production by Region (2021-2026) & (US$/mL)
Table 7. World NHS-Activated MagBeads Production by Region (2027-2032) & (US$/mL)
Table 8. World NHS-Activated MagBeads Production Market Share by Region (2021-2026)
Table 9. World NHS-Activated MagBeads Production Market Share by Region (2027-2032)
Table 10. World NHS-Activated MagBeads Average Price by Region (2021-2026) & (US$/Milliliter)
Table 11. World NHS-Activated MagBeads Average Price by Region (2027-2032) & (US$/Milliliter)
Table 12. NHS-Activated MagBeads Major Market Trends
Table 13. World NHS-Activated MagBeads Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (US$/mL)
Table 14. World NHS-Activated MagBeads Consumption by Region (2021-2026) & (US$/mL)
Table 15. World NHS-Activated MagBeads Consumption Forecast by Region (2027-2032) & (US$/mL)
Table 16. World NHS-Activated MagBeads Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key NHS-Activated MagBeads Producers in 2025
Table 18. World NHS-Activated MagBeads Production by Manufacturer (2021-2026) & (US$/mL)
Table 19. Production Market Share of Key NHS-Activated MagBeads Producers in 2025
Table 20. World NHS-Activated MagBeads Average Price by Manufacturer (2021-2026) & (US$/Milliliter)
Table 21. Global NHS-Activated MagBeads Company Evaluation Quadrant
Table 22. World NHS-Activated MagBeads Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and NHS-Activated MagBeads Production Site of Key Manufacturer
Table 24. NHS-Activated MagBeads Market: Company Product Type Footprint
Table 25. NHS-Activated MagBeads Market: Company Product Application Footprint
Table 26. NHS-Activated MagBeads Competitive Factors
Table 27. NHS-Activated MagBeads New Entrant and Capacity Expansion Plans
Table 28. NHS-Activated MagBeads Mergers & Acquisitions Activity
Table 29. United States VS China NHS-Activated MagBeads Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China NHS-Activated MagBeads Production Comparison, (2021 & 2025 & 2032) & (US$/mL)
Table 31. United States VS China NHS-Activated MagBeads Consumption Comparison, (2021 & 2025 & 2032) & (US$/mL)
Table 32. United States Based NHS-Activated MagBeads Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers NHS-Activated MagBeads Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers NHS-Activated MagBeads Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers NHS-Activated MagBeads Production (2021-2026) & (US$/mL)
Table 36. United States Based Manufacturers NHS-Activated MagBeads Production Market Share (2021-2026)
Table 37. China Based NHS-Activated MagBeads Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers NHS-Activated MagBeads Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers NHS-Activated MagBeads Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers NHS-Activated MagBeads Production, (2021-2026) & (US$/mL)
Table 41. China Based Manufacturers NHS-Activated MagBeads Production Market Share (2021-2026)
Table 42. Rest of World Based NHS-Activated MagBeads Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers NHS-Activated MagBeads Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers NHS-Activated MagBeads Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers NHS-Activated MagBeads Production, (2021-2026) & (US$/mL)
Table 46. Rest of World Based Manufacturers NHS-Activated MagBeads Production Market Share (2021-2026)
Table 47. World NHS-Activated MagBeads Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World NHS-Activated MagBeads Production by Type (2021-2026) & (US$/mL)
Table 49. World NHS-Activated MagBeads Production by Type (2027-2032) & (US$/mL)
Table 50. World NHS-Activated MagBeads Production Value by Type (2021-2026) & (USD Million)
Table 51. World NHS-Activated MagBeads Production Value by Type (2027-2032) & (USD Million)
Table 52. World NHS-Activated MagBeads Average Price by Type (2021-2026) & (US$/Milliliter)
Table 53. World NHS-Activated MagBeads Average Price by Type (2027-2032) & (US$/Milliliter)
Table 54. World NHS-Activated MagBeads Production Value by Particle Size, (USD Million), 2021 & 2025 & 2032
Table 55. World NHS-Activated MagBeads Production by Particle Size (2021-2026) & (US$/mL)
Table 56. World NHS-Activated MagBeads Production by Particle Size (2027-2032) & (US$/mL)
Table 57. World NHS-Activated MagBeads Production Value by Particle Size (2021-2026) & (USD Million)
Table 58. World NHS-Activated MagBeads Production Value by Particle Size (2027-2032) & (USD Million)
Table 59. World NHS-Activated MagBeads Average Price by Particle Size (2021-2026) & (US$/Milliliter)
Table 60. World NHS-Activated MagBeads Average Price by Particle Size (2027-2032) & (US$/Milliliter)
Table 61. World NHS-Activated MagBeads Production Value by Suspension Concentration, (USD Million), 2021 & 2025 & 2032
Table 62. World NHS-Activated MagBeads Production by Suspension Concentration (2021-2026) & (US$/mL)
Table 63. World NHS-Activated MagBeads Production by Suspension Concentration (2027-2032) & (US$/mL)
Table 64. World NHS-Activated MagBeads Production Value by Suspension Concentration (2021-2026) & (USD Million)
Table 65. World NHS-Activated MagBeads Production Value by Suspension Concentration (2027-2032) & (USD Million)
Table 66. World NHS-Activated MagBeads Average Price by Suspension Concentration (2021-2026) & (US$/Milliliter)
Table 67. World NHS-Activated MagBeads Average Price by Suspension Concentration (2027-2032) & (US$/Milliliter)
Table 68. World NHS-Activated MagBeads Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World NHS-Activated MagBeads Production by Application (2021-2026) & (US$/mL)
Table 70. World NHS-Activated MagBeads Production by Application (2027-2032) & (US$/mL)
Table 71. World NHS-Activated MagBeads Production Value by Application (2021-2026) & (USD Million)
Table 72. World NHS-Activated MagBeads Production Value by Application (2027-2032) & (USD Million)
Table 73. World NHS-Activated MagBeads Average Price by Application (2021-2026) & (US$/Milliliter)
Table 74. World NHS-Activated MagBeads Average Price by Application (2027-2032) & (US$/Milliliter)
Table 75. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 76. Thermo Fisher Scientific Major Business
Table 77. Thermo Fisher Scientific NHS-Activated MagBeads Product and Services
Table 78. Thermo Fisher Scientific NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 81. Agilent Basic Information, Manufacturing Base and Competitors
Table 82. Agilent Major Business
Table 83. Agilent NHS-Activated MagBeads Product and Services
Table 84. Agilent NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Agilent Recent Developments/Updates
Table 86. Agilent Competitive Strengths & Weaknesses
Table 87. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 88. Miltenyi Biotec Major Business
Table 89. Miltenyi Biotec NHS-Activated MagBeads Product and Services
Table 90. Miltenyi Biotec NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Miltenyi Biotec Recent Developments/Updates
Table 92. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 93. Bioclone Basic Information, Manufacturing Base and Competitors
Table 94. Bioclone Major Business
Table 95. Bioclone NHS-Activated MagBeads Product and Services
Table 96. Bioclone NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Bioclone Recent Developments/Updates
Table 98. Bioclone Competitive Strengths & Weaknesses
Table 99. Cube Biotech Basic Information, Manufacturing Base and Competitors
Table 100. Cube Biotech Major Business
Table 101. Cube Biotech NHS-Activated MagBeads Product and Services
Table 102. Cube Biotech NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Cube Biotech Recent Developments/Updates
Table 104. Cube Biotech Competitive Strengths & Weaknesses
Table 105. Cytiva Basic Information, Manufacturing Base and Competitors
Table 106. Cytiva Major Business
Table 107. Cytiva NHS-Activated MagBeads Product and Services
Table 108. Cytiva NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Cytiva Recent Developments/Updates
Table 110. Cytiva Competitive Strengths & Weaknesses
Table 111. CD Bioparticles Basic Information, Manufacturing Base and Competitors
Table 112. CD Bioparticles Major Business
Table 113. CD Bioparticles NHS-Activated MagBeads Product and Services
Table 114. CD Bioparticles NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. CD Bioparticles Recent Developments/Updates
Table 116. CD Bioparticles Competitive Strengths & Weaknesses
Table 117. BEAVER Basic Information, Manufacturing Base and Competitors
Table 118. BEAVER Major Business
Table 119. BEAVER NHS-Activated MagBeads Product and Services
Table 120. BEAVER NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. BEAVER Recent Developments/Updates
Table 122. BEAVER Competitive Strengths & Weaknesses
Table 123. Beijing Biomed Gene Technology Basic Information, Manufacturing Base and Competitors
Table 124. Beijing Biomed Gene Technology Major Business
Table 125. Beijing Biomed Gene Technology NHS-Activated MagBeads Product and Services
Table 126. Beijing Biomed Gene Technology NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Beijing Biomed Gene Technology Recent Developments/Updates
Table 128. Beijing Biomed Gene Technology Competitive Strengths & Weaknesses
Table 129. Yeasen Biotechnology Basic Information, Manufacturing Base and Competitors
Table 130. Yeasen Biotechnology Major Business
Table 131. Yeasen Biotechnology NHS-Activated MagBeads Product and Services
Table 132. Yeasen Biotechnology NHS-Activated MagBeads Production (US$/mL), Price (US$/Milliliter), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Yeasen Biotechnology Recent Developments/Updates
Table 134. Yeasen Biotechnology Competitive Strengths & Weaknesses
Table 135. Global Key Players of NHS-Activated MagBeads Upstream (Raw Materials)
Table 136. Global NHS-Activated MagBeads Typical Customers
Table 137. NHS-Activated MagBeads Typical Distributors

LIST OF FIGURES

Figure 1. NHS-Activated MagBeads Picture
Figure 2. World NHS-Activated MagBeads Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World NHS-Activated MagBeads Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World NHS-Activated MagBeads Production (2021-2032) & (US$/mL)
Figure 5. World NHS-Activated MagBeads Average Price (2021-2032) & (US$/Milliliter)
Figure 6. World NHS-Activated MagBeads Production Value Market Share by Region (2021-2032)
Figure 7. World NHS-Activated MagBeads Production Market Share by Region (2021-2032)
Figure 8. North America NHS-Activated MagBeads Production (2021-2032) & (US$/mL)
Figure 9. Europe NHS-Activated MagBeads Production (2021-2032) & (US$/mL)
Figure 10. China NHS-Activated MagBeads Production (2021-2032) & (US$/mL)
Figure 11. Japan NHS-Activated MagBeads Production (2021-2032) & (US$/mL)
Figure 12. NHS-Activated MagBeads Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World NHS-Activated MagBeads Consumption (2021-2032) & (US$/mL)
Figure 15. World NHS-Activated MagBeads Consumption Market Share by Region (2021-2032)
Figure 16. United States NHS-Activated MagBeads Consumption (2021-2032) & (US$/mL)
Figure 17. China NHS-Activated MagBeads Consumption (2021-2032) & (US$/mL)
Figure 18. Europe NHS-Activated MagBeads Consumption (2021-2032) & (US$/mL)
Figure 19. Japan NHS-Activated MagBeads Consumption (2021-2032) & (US$/mL)
Figure 20. South Korea NHS-Activated MagBeads Consumption (2021-2032) & (US$/mL)
Figure 21. ASEAN NHS-Activated MagBeads Consumption (2021-2032) & (US$/mL)
Figure 22. India NHS-Activated MagBeads Consumption (2021-2032) & (US$/mL)
Figure 23. Producer Shipments of NHS-Activated MagBeads by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for NHS-Activated MagBeads Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for NHS-Activated MagBeads Markets in 2025
Figure 26. United States VS China: NHS-Activated MagBeads Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: NHS-Activated MagBeads Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: NHS-Activated MagBeads Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers NHS-Activated MagBeads Production Market Share 2025
Figure 30. China Based Manufacturers NHS-Activated MagBeads Production Market Share 2025
Figure 31. Rest of World Based Manufacturers NHS-Activated MagBeads Production Market Share 2025
Figure 32. World NHS-Activated MagBeads Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World NHS-Activated MagBeads Production Value Market Share by Type in 2025
Figure 34. Agarose Based
Figure 35. Silicon Based
Figure 36. Starch Based
Figure 37. World NHS-Activated MagBeads Production Market Share by Type (2021-2032)
Figure 38. World NHS-Activated MagBeads Production Value Market Share by Type (2021-2032)
Figure 39. World NHS-Activated MagBeads Average Price by Type (2021-2032) & (US$/Milliliter)
Figure 40. World NHS-Activated MagBeads Production Value by Particle Size, (USD Million), 2021 & 2025 & 2032
Figure 41. World NHS-Activated MagBeads Production Value Market Share by Particle Size in 2025
Figure 42. Particle Size<50?m
Figure 43. Particle Size50-100?m
Figure 44. Particle Size>100?m
Figure 45. World NHS-Activated MagBeads Production Market Share by Particle Size (2021-2032)
Figure 46. World NHS-Activated MagBeads Production Value Market Share by Particle Size (2021-2032)
Figure 47. World NHS-Activated MagBeads Average Price by Particle Size (2021-2032) & (US$/Milliliter)
Figure 48. World NHS-Activated MagBeads Production Value by Suspension Concentration, (USD Million), 2021 & 2025 & 2032
Figure 49. World NHS-Activated MagBeads Production Value Market Share by Suspension Concentration in 2025
Figure 50. Suspension Concentration 10% (V/V)
Figure 51. Suspension Concentration 20% (V/V)
Figure 52. Suspension Concentration 25% (V/V)
Figure 53. World NHS-Activated MagBeads Production Market Share by Suspension Concentration (2021-2032)
Figure 54. World NHS-Activated MagBeads Production Value Market Share by Suspension Concentration (2021-2032)
Figure 55. World NHS-Activated MagBeads Average Price by Suspension Concentration (2021-2032) & (US$/Milliliter)
Figure 56. World NHS-Activated MagBeads Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World NHS-Activated MagBeads Production Value Market Share by Application in 2025
Figure 58. Protein Purification
Figure 59. Immunoassay
Figure 60. Cell Screening
Figure 61. Others
Figure 62. World NHS-Activated MagBeads Production Market Share by Application (2021-2032)
Figure 63. World NHS-Activated MagBeads Production Value Market Share by Application (2021-2032)
Figure 64. World NHS-Activated MagBeads Average Price by Application (2021-2032) & (US$/Milliliter)
Figure 65. NHS-Activated MagBeads Industry Chain
Figure 66. NHS-Activated MagBeads Procurement Model
Figure 67. NHS-Activated MagBeads Sales Model
Figure 68. NHS-Activated MagBeads Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source


More Publications